Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Thorne Healthtech, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
09/27/2023 |
8-K
| Other Events Interactive Data |
08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
08/08/2023 |
8-K
| Quarterly results
Docs:
|
"Thorne HealthTech Reports Second Quarter 2023 Results Record Net Sales With Growth of 33.1%; Raises Full-Year Guidance Midpoints for Net Sales and Gross Margin NEW YORK, August 8, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. , a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023. Second Quarter Highlights: • Net sales grew 33.1% year-over-year to $72.7 million, with direct-to-consumer sales growth of 39.3% • Gross profit grew 35.7% year-over-year to $40.6 million; gross profit as a % of net sales increased year-over-year to 55.9%. • Net income attributable to Thorne HealthTech, Inc. of $4.4 million; adjusted EBITDA1 of $12.5 mi..." |
|
06/01/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
05/11/2023 |
8-K
| Quarterly results
Docs:
|
"Thorne HealthTech Reports First Quarter 2023 Results Net Sales Growth of 20.7%; Reaffirms Full-Year 2023 Guidance NEW YORK, May 11, 2023 /PRNewswire/ -- Thorne HealthTech, Inc. , a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the first quarter ended March 31, 2023. First Quarter Highlights: • Net sales grew 20.7% year-over-year to $65.2 million, with direct-to-consumer sales growth of 41.0% • Gross profit grew 16.3% year-over-year to $34.3 million; gross profit as a % of net sales decreased year-over-year to 52.5% • Net loss attributable to Thorne HealthTech, Inc. of $ million; adjusted EBITDA1 of $6.1 million • Diluted earnings per share of $; adjusted..." |
|
04/03/2023 |
8-K/A
| Results of Operations and Financial Condition Interactive Data |
03/13/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
02/03/2023 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Other Events, Financial State...
Docs:
|
"STOCK PURCHASE AGREEMENT THIS STOCK PURCHASE AGREEMENT, dated as of January 31, 2023 , is by and between PreCon Acquisition LLC, a Delaware limited liability company , Thorne HealthTech, Inc., a South Carolina corporation , and for purposes of Sections 1.6 and 5.5 and Article VI, Eigenlyfe LLC, a Delaware limited liability company . Each of Seller and Purchaser are referred to as a “Party” and are collectively referred to as the “Parties.” WITNESSETH: WHEREAS, Seller owns all of the issued and outstanding shares of capital stock of PreCon Health, Inc., a Delaware corporation ; WHEREAS, Purchaser desires to own, indirectly, the assets of the Company, including: the SynaQuell and SynaQuell + nutritional supplement products ; all intellectual property presently own...",
"THORNE HEALTHTECH ACQUIRES PRECON HEALTH Acquisition of PreCon strengthens brain health portfolio and provides access to world-class scientific advisory board NEW YORK – Feb. 3, 2023 – Thorne HealthTech, Inc. (“Thorne” or “Thorne HealthTech”" |
|
01/04/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
11/09/2022 |
8-K
| Quarterly results |
08/09/2022 |
8-K
| Quarterly results |
06/06/2022 |
8-K
| Quarterly results |
05/11/2022 |
8-K
| Quarterly results |
04/12/2022 |
8-K
| Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs:
|
"Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER DOCUMENT EXECUTED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY . EACH PARTY HERETO CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER DOCUMENTS CONTEMPLATED HEREBY BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS S...",
"SECURITY AGREEMENT 1. THE SECURITY. The undersigned Thorne HealthTech, Inc., a Delaware corporation, and Thorne Research, Inc., a South Carolina corporation hereby assigns and grants to Bank of America, N.A., its successors and assigns , and to Bank of America Corporation and its subsidiaries and affiliates a security interest in the following described property now owned or hereafter acquired by the Pledgor : All accounts, and all chattel paper, instruments, deposit accounts, letter of credit rights, and general intangibles related thereto; and all returned or repossessed goods which, on sale or lease, resulted in an account. All inventory. All equipment and fixtures now owned or hereafter acquired by the Pledgor, . All of the Pledgor’s deposit accounts with the Bank. The Collateral shall...",
"Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS GUARANTY OR ANY OTHER DOCUMENT EXECUTED IN CONNECTION HEREWITH OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY . EACH PARTY HERETO CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS GUARANTY AND THE OTHER DOCUMENTS CONTEMPLATED HEREBY BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SEC..." |
|
03/23/2022 |
8-K
| Quarterly results |
03/16/2022 |
8-K/A
| Quarterly results |
03/14/2022 |
8-K
| Quarterly results |
03/04/2022 |
8-K
| Quarterly results |
01/13/2022 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
12/14/2021 |
8-K
| Quarterly results |
12/06/2021 |
8-K
| Quarterly results |
12/03/2021 |
8-K
| Quarterly results |
11/10/2021 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
|
|